Meeder Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-26
Closed -$1.66K 1000
2025
Q1
$1.66K Sell
26
-6
-19% -$383 ﹤0.01% 876
2024
Q4
$3.89K Sell
32
-514
-94% -$62.5K ﹤0.01% 859
2024
Q3
$68.2K Buy
546
+21
+4% +$2.62K ﹤0.01% 328
2024
Q2
$83K Buy
525
+492
+1,491% +$77.7K 0.01% 278
2024
Q1
$4.27K Buy
+33
New +$4.27K ﹤0.01% 650
2022
Q3
Sell
-4
Closed 2359
2022
Q2
$0 Sell
4
-22
-85% ﹤0.01% 2419
2022
Q1
$2K Buy
+26
New +$2K ﹤0.01% 2080
2021
Q4
Sell
-14
Closed -$1K 2186
2021
Q3
$1K Sell
14
-4
-22% -$286 ﹤0.01% 2372
2021
Q2
$1K Sell
18
-1
-5% -$56 ﹤0.01% 2392
2021
Q1
$1K Sell
19
-17
-47% -$895 ﹤0.01% 2263
2020
Q4
$6K Buy
36
+1
+3% +$167 ﹤0.01% 1174
2020
Q3
$5K Sell
35
-7
-17% -$1K ﹤0.01% 1593
2020
Q2
$7K Sell
42
-25
-37% -$4.17K ﹤0.01% 1437
2020
Q1
$7K Sell
67
-5
-7% -$522 ﹤0.01% 1671
2019
Q4
$9K Buy
72
+45
+167% +$5.63K ﹤0.01% 1597
2019
Q3
$2K Sell
27
-202
-88% -$15K ﹤0.01% 1984
2019
Q2
$35K Sell
229
-4,980
-96% -$761K ﹤0.01% 1055
2019
Q1
$620K Buy
5,209
+2,644
+103% +$315K 0.05% 343
2018
Q4
$281K Buy
2,565
+2,416
+1,621% +$265K 0.03% 430
2018
Q3
$24K Sell
149
-272
-65% -$43.8K ﹤0.01% 984
2018
Q2
$55.6K Buy
+421
New +$55.6K ﹤0.01% 731
2018
Q1
Sell
-30
Closed -$2K 1732
2017
Q4
$2K Sell
30
-44
-59% -$2.93K ﹤0.01% 1505
2017
Q3
$3K Buy
+74
New +$3K ﹤0.01% 1386
2017
Q2
Sell
-103
Closed -$3K 1852
2017
Q1
$3K Buy
+103
New +$3K ﹤0.01% 1280